Abstract:Abstract Objective Basic transcription factor 3 (BTF3) has been shown to exert carcinogenic effects in several types of tumors. But its role in melanoma is still unclear. This study aims to explore the proliferative effect and molecular mechanisms of BTF3 in melanoma. Methods We used GFP-labeled BTF3-shRNA lentiviral vectors to knock down the expression of the BTF3 gene in melanoma cells, and then evaluated the effect of BTF3 on the cell proliferation, cell cycle, apoptosis, and colony formation of melanoma cells through in vivo and in vitro experiments. Furthermore, we selected the representative tumor masses from the xenografted melanoma for microarray hybridization and bio-information analysis to screen out genes that significantly interact with BTF3. Through conducting hierarchical clustering analyze we predicted the prominent pathways and biological effects of BTF3-ralated genes, and further verify the expression of some representative genes by qRT-PCR and western blot. Results BTF3 is heterogeneously expressed in melanoma tissues and cells. Knockdown the expression of BTF3 attenuated the proliferation of melanoma cells both in vitro and in vivo. The melanoma cells exhibited more apoptosis, significant G2/M arrest, and deficient DNA damage repair capability conferred by transfection of BTF3-shRNA lentiviral vector. Furthermore, the results of bioinformatics analysis and western blot assay suggested that BTF3 might involve in p53 signaling, complement system, wnt/β-catenin signaling, FGF signaling, and other classical signaling pathways through interacting with some important genes such as TP53, cyclin dependent kinase inhibitor 1A (CDKN1A), checkpoint kinase 1 (CHEK1), tumor protein p53 inducible protein 3 (TP53I3), and insulin like growth factor binding protein 3 (IGFBP3). The upstream regulators of BTF3 include doxorubicin, nuclear protein 1 (NUPR1), TP53, etc. Conclusion BTF3 promotes the progression of melanoma by interacting with some key genes such as p53. Our findings provide novel insights into the role of BTF3 as an oncogenic gene in melanoma and suggest that BTF3 expression level may serve as a potential biomarker in response to clinical treatment.

The oncogenic function and potential mechanism of basic transcription factor 3 in melanoma

Study on the correlation between the expression of basic transcription factor 3 (BTF3) and the efficacy and prognosis of patients with malignant melanoma (MM).

Prognostic significance of RUNX3 expression in human melanoma.

Effects of RNA Methylation N6-methyladenosine Regulators on Malignant Progression and Prognosis of Melanoma.

BTF3 Confers Oncogenic Activity in Prostate Cancer Through Transcriptional Upregulation of Replication Factor C

Basic Transcription Factor 3 Expression Silencing Attenuates Colon Cancer Cell Proliferation and Migration in Vitro

Basic Transcription Factor 3 Like 4 Enhances Malignant Phenotypes through Modulating Tumor Cell Function and Immune Microenvironment in Glioma

E2F3 Promotes Cancer Growth and is Overexpressed Through Copy Number Variation in Human Melanoma

TCF3 as a multidimensional biomarker: oncogenicity, genomic alterations, and immune landscape in pan-cancer analysis

BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1

UBTF facilitates melanoma progression via modulating MEK1/2-ERK1/2 signalling pathways by promoting GIT1 transcription

An essential role for DNA methyltransferase 3a in melanoma tumorigenesis

Signal Transducer and Activator of Transcription 3 and Melanoma

BTF3 Sustains Cancer Stem-Like Phenotype of Prostate Cancer Via Stabilization of BMI1

796 the Up-Regulated Ubiquitin Ligase TNFAIP3 Plays an Oncogenic Role in Melanoma

Tumour suppressor candidate 3 inhibits biological function and increases endoplasmic reticulum stress of melanoma cells WM451 by regulating AKT/GSK3‐β/β‐catenin pathway

Identification of TDP-43 As an Oncogene in Melanoma and Its Function During Melanoma Pathogenesis.

MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.

The Role of TGFBR3 in the Development of Lung Cancer

A Genomic Screen Identifies Tyro3 As A Mitf Regulator in Melanoma

BTF3 Promotes Stemness and Inhibits TypeⅠInterferon Signaling Pathway in Triple-Negative Breast Cancer.